- Home
- IMMX vs HKIT Comparison
IMMX vs HKIT Comparison
Compare IMMX & HKIT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMMX
- HKIT
- Stock Information
- Founded
- IMMX 2014
- HKIT 1996
- Country
- IMMX United States
- HKIT China
- Employees
- IMMX N/A
- HKIT N/A
- Industry
- IMMX Medicinal Chemicals and Botanical Products
- HKIT Computer Software: Prepackaged Software
- Sector
- IMMX Health Care
- HKIT Technology
- Exchange
- IMMX Nasdaq
- HKIT Nasdaq
- Market Cap
- IMMX 61.1M
- HKIT 45.4M
- IPO Year
- IMMX 2021
- HKIT 2023
- Fundamental
- Price
- IMMX $2.17
- HKIT $1.31
- Analyst Decision
- IMMX Strong Buy
- HKIT
- Analyst Count
- IMMX 1
- HKIT 0
- Target Price
- IMMX $7.00
- HKIT N/A
- AVG Volume (30 Days)
- IMMX 269.5K
- HKIT 26.7K
- Earning Date
- IMMX 11-12-2024
- HKIT 12-31-2024
- Dividend Yield
- IMMX N/A
- HKIT N/A
- EPS Growth
- IMMX N/A
- HKIT N/A
- EPS
- IMMX N/A
- HKIT 0.04
- Revenue
- IMMX N/A
- HKIT $3,449,206.00
- Revenue This Year
- IMMX N/A
- HKIT N/A
- Revenue Next Year
- IMMX $200.00
- HKIT N/A
- P/E Ratio
- IMMX N/A
- HKIT $34.32
- Revenue Growth
- IMMX N/A
- HKIT N/A
- 52 Week Low
- IMMX $1.26
- HKIT $0.54
- 52 Week High
- IMMX $7.50
- HKIT $6.48
- Technical
- Relative Strength Index (RSI)
- IMMX 53.37
- HKIT 43.90
- Support Level
- IMMX $1.88
- HKIT $1.28
- Resistance Level
- IMMX $2.44
- HKIT $1.41
- Average True Range (ATR)
- IMMX 0.32
- HKIT 0.11
- MACD
- IMMX -0.02
- HKIT -0.00
- Stochastic Oscillator
- IMMX 34.94
- HKIT 15.28
About IMMX Immix Biopharma Inc.
Immix Biopharma Inc is engaged in the discovery and development of novel cell therapies for hematologic malignancies (blood cancers) and other indications. It is a clinical-stage biopharmaceutical company developing a novel class of Tissue-Specific Therapeutics TM in oncology and inflammation. Its TME Normalization Technology allows drug candidates to circulate in the bloodstream, exit through tumor blood vessels and simultaneously attack all components of the TME. Its product candidates include CAR-T NXC-201 for autoimmune diseases, and IMX-110 for treatment of soft tissue sarcoma.
About HKIT Hitek Global Inc.
Hitek Global Inc is a provider of information technology consulting and solutions services. The company has two lines of businesses such as services to small and medium businesses, which consist of Anti-Counterfeiting Tax Control System tax devices, including Golden Tax Disk and printers, ACTCS services, and IT services; and services to large businesses, which include hardware sales and software sales. It generates revenues from hardware sales, software sales, IT services, and tax devices and services.